Maja Zorovic
Overview
Explore the profile of Maja Zorovic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
78
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Elersic K, Banjac A, Zivin M, Zorovic M
J Psychiatr Res
. 2025 Mar;
184:307-317.
PMID: 40081264
Ketamine, a fast-acting antidepressant, is a racemic mixture, composed of equal amounts of R- and S-ketamine. Preclinical studies are comparing them to better understand their role in therapeutic and undesirable...
2.
Elersic K, Banjac A, Zivin M, Zorovic M
PLoS One
. 2024 Mar;
19(3):e0299379.
PMID: 38427622
Ketamine has gained significant attention as a fast-acting antidepressant. However, ketamine is also associated with undesirable side effects. In our preclinical study, we explored the behavioral effects of ketamine enantiomers...
3.
Slabe Z, Pechler G, van Heerikhuize J, Samuels B, Zivin M, Zorovic M, et al.
Neurobiol Dis
. 2023 Jun;
183:106191.
PMID: 37290577
The mood disorders major depressive disorder (MDD) and bipolar disorder (BD) are highly prevalent worldwide. Women are more vulnerable to these psychopathologies than men. The bed nucleus of the stria...
4.
Slabe Z, Balesar R, Verwer R, Van Heerikhuize J, Pechler G, Zorovic M, et al.
Psychol Med
. 2023 May;
53(16):7537-7549.
PMID: 37226771
Background: Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) is involved in the stress response and may play a key role in mood disorders, but no information is available on PACAP for the...
5.
Meden A, Knez D, Brazzolotto X, Modeste F, Perdih A, Pislar A, et al.
Eur J Med Chem
. 2022 Dec;
247:115048.
PMID: 36586299
Alongside reversible butyrylcholinesterase inhibitors, a plethora of covalent butyrylcholinesterase inhibitors have been reported in the literature, typically pseudo-irreversible carbamates. For these latter, however, most cases lack full confirmation of their...
6.
Ivanusec A, Sribar J, Leonardi A, Zorovic M, Zivin M, Krizaj I
Int J Mol Sci
. 2022 Oct;
23(20).
PMID: 36293221
Alzheimer's disease (AD), a progressive form of dementia, is characterized by the increased expression of secreted phospholipase A group IIA (GIIA) in the affected tissue and the dysfunction of neuronal...
7.
Kolmancic K, Zivin M, Zorovic M
Life (Basel)
. 2022 May;
12(5).
PMID: 35629308
Treatment with levodopa (L-dopa) in Parkinson's disease (PD) leads to involuntary movements termed L-dopa-induced dyskinesia (LID). There are contradictory data about the influence of hormone therapy in female PD patients...
8.
Zorovic M, Kolmancic K, Zivin M
Bosn J Basic Med Sci
. 2021 Apr;
21(6):702-711.
PMID: 33823126
Parkinson's disease (PD) is a long-term degenerative disorder of the central nervous system that mainly affects the motor system. Dopamine precursor levodopa (L-dopa) is used as the first-line treatment for...
9.
Development of potent reversible selective inhibitors of butyrylcholinesterase as fluorescent probes
Pajk S, Knez D, Kosak U, Zorovic M, Brazzolotto X, Coquelle N, et al.
J Enzyme Inhib Med Chem
. 2020 Jan;
35(1):498-505.
PMID: 31914836
Brain butyrylcholinesterase (BChE) is an attractive target for drugs designed for the treatment of Alzheimer's disease (AD) in its advanced stages. It also potentially represents a biomarker for progression of...
10.
Presern J, Polajnar J, de Groot M, Zorovic M, Virant-Doberlet M
Sci Rep
. 2018 Apr;
8(1):5418.
PMID: 29615688
Although vibrational signalling is among the most ancient and common forms of communication, many fundamental aspects of this communication channel are still poorly understood. Here, we studied mechanisms underlying orientation...